Hemostatic Abnormalities in Multiple Myeloma Patients
Conclusion: This
study provided laboratory evidence of hemostatic dysfunction which may be associated with thrombotic or bleeding
complications at diagnosis in all MM patients. Hence, screening for these abnormalities at the time of diagnosis should
help improved prognosis in such cases.
PMID: 29373903 [PubMed - as supplied by publisher]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Laboratory Medicine | Lupus | Myeloma | Study | Thrombocytopenia | Thrombosis